Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Merck Targets Toughest Cases to Gain Hepatitis C Foothold
Bloomberg
Mon, 08/3/15 - 05:10 pm
Tags:
Merck, Gilead Sciences, AbbVie, hepatitis C, Viekira Pak, Harvoni, Sovaldi, grazoprevir/elbasvir
New drug approval is a win for the Bay State's horse in the hepatitis C race
Bizjournals.com
Tue, 07/28/15 - 12:34 pm
Tags:
Enanta Pharmaceuticals, AbbVie, Technivie, hepatitis C
AbbVie, Bristol-Myers get FDA nod for hep C treatments
Yahoo/Reuters
Fri, 07/24/15 - 05:40 pm
Tags:
AbbVie, Bristol-Myers Squibb, hepatitis C, FDA, Technivie, Daklinza
AbbVie reports first revenue miss in six quarters
Yahoo/Reuters
Fri, 07/24/15 - 10:07 am
Tags:
AbbVie, earnings
What to Expect From AbbVie Earnings
Yahoo/24 7 Wall St
Thu, 07/23/15 - 11:05 pm
Tags:
AbbVie, earnings
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
Tags:
biosimilars, AbbVie, Roche, Amgen, Rituxan, Herceptin, Avastin, Neupogen, Neulasta, Epogen, Humira, Perjeta, Gazyva
2015’s Top 6 Big Pharma Headlines Thus Far
Motley Fool
Wed, 07/22/15 - 08:36 am
Tags:
Pfizer, M&A, Hospira, AbbVie, Pharmacyclics, PCSK9 inhibitors, Amgen, Sanofi, Regeneron, Express Scripts, Bristol-Myers Squibb, Opdivo
FDA grants AbbVie's anti-tau drug orphan status
BioPharma Dive
Mon, 07/20/15 - 11:07 am
Tags:
FDA, AbbVie, anti-tau antibodies, ABBV-8E12, progressive supranuclear palsy, C2N Diagnostics
6 Big-Cap Drugmakers Reporting Earnings Next Week
Investors.com
Sat, 07/18/15 - 11:00 am
Tags:
earnings, Novartis, Bristol-Myers Squibb, Eli Lilly, Valeant Pharmaceuticals, AbbVie, Biogen
3 Top Big Pharmaceutical Stocks With Upcoming Catalysts
24/7 Wall St
Tue, 07/14/15 - 11:44 am
Tags:
AbbVie, Humira, Cyramza, Eli Lilly, generics, Evista, Cymbalta, Pfizer, Ibrance
Shire Deepens Push Into Biotech After AbbVie Drops Bid
WSJ Online
Mon, 07/13/15 - 07:33 pm
Tags:
Shire, AbbVie, M&A
Fast-paced changes in drugs for hepatitis C seen as harbinger of rising US health care costs
Yahoo/AP
Sat, 07/11/15 - 10:20 am
Tags:
drug pricing, hepatitis C, Harvoni, Sovaldi, AbbVie, Gilead Sciences, Viekira Pak
Gilead Sciences: Does Anyone Care About Hep-C Anymore?
Barron's
Fri, 07/10/15 - 01:43 pm
Tags:
Gilead Sciences, hepatitis C, AbbVie, Harvoni, Sovaldi, Viekira Pak
Johnson & Johnson: Experimental drug clears more psoriasis patches than rival AbbVie's Humira
Yahoo/AP
Thu, 07/9/15 - 10:13 am
Tags:
JNJ, AbbVie, psoriasis, guselkumab
Merck and Samsung's Humira biosimilar comes through in Phase III
Fierce Biotech
Wed, 07/8/15 - 09:23 am
Tags:
Merck, Humira, biosimilars, SB5, Samsung Bioepis, AbbVie, rheumatoid arthritis
AbbVie has room to cut marketing spend if Humira biosims start hurting: analysts
Fierce Pharma Marketing
Wed, 07/1/15 - 12:09 pm
Tags:
AbbVie, Humira, biosimilars
AbbVie hepatitis C cocktail succeeds in late-stage study
Reuters
Wed, 06/24/15 - 10:20 am
Tags:
AbbVie, hepatitis C, Viekira Pak
Chi-Med Arthritis Drug Spurs Interest From Possible Partners
Bloomberg
Fri, 06/19/15 - 10:06 am
Tags:
Chi-Med, HMPL-523, rheumatoid arthritis, Imbruvica, AbbVie
Bad news for AbbVie: Humira copies expected to rack up biggest biosim sales
Fierce Pharma
Tue, 06/16/15 - 12:15 pm
Tags:
AbbVie, Humira, biosimilars, Pharmacyclics
AbbVie creates new position to expand global philanthropy
Bizjournals.com
Mon, 06/15/15 - 09:02 pm
Tags:
philanthropy, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.